By Ethan Covey
Real-world data have shown that the monkeypox (mpox) modified vaccinia Ankara vaccine (Jynneos, Bavarian Nordic) is both safe and effective in reducing risk for infection, according to a pair of newly released CDC reports.
The vaccine is a live, nonreplicating viral vaccine licensed for the prevention of smallpox and mpox in adults who are at least 18 years of age, administered as a 0.5-mL two-dose series given 28 days apart by subcutaneous injection. On Aug. 9, 2022, the FDA